Exelon Corporation vs Southern Company (The) — Stock Comparison
Q·Score Breakdown
5.9
Hold
Overall
5.9
Hold
Quality
Health
Growth
Valuation
Sentiment
EXC
Trading at an attractive 15.6× forward earnings.
⚠ cautious analyst consensus — few Buy ratings.
SO
Strong profitability with 15% net profit margins.
⚠ cautious analyst consensus — few Buy ratings.
Analyst Consensus
HOLD
Target $50.22 (+6.2%)
18 analysts
HOLD
Target $101.45 (+5.8%)
19 analysts
Fundamentals
EXC
SO
17.3×
Trailing P/E
24.5×
15.6×
Forward P/E
19.5×
11.4%
Profit Margin
14.7%
42.9%
Gross Margin
48.5%
9.9%
ROE
11.0%
-1.1%
Revenue Growth
10.1%
-9.3%
Earnings Growth
-22.1%
0.51
Beta
0.41
—
Price / Book
—
$48.4B
Market Cap
$108.1B
$42 – $51
52-Week Range
$83 – $101
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.